It’s J.P. Morgan time — so all biopharma eyes will be attuned to the dallyings and dealings taking place this week in the hallowed halls of San Francisco’s Westin St. Francis. Of course, there are plenty of ancillary events going on (like the Biotech Showcase — which has become nearly as popular), so here’s what we’re watching out for in the worlds of pharma and biotech:

The J.P. Morgan Healthcare Conference

Well, yeah. Plenty of illuminating sessions to come during the premier biopharma event of the year. Standout sessions on Monday include Illumina, Biogen, and NantHealth. On Tuesday? We’re particularly curious about what Sarepta, Axovant, Juno Therapeutics, and especially Valeant Pharmaceuticals have to say for themselves. The past year’s been rife with news — and some controversy — from these companies.

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.

Leave a Comment

Please enter your name.
Please enter a comment.

Sign up for our Morning Rounds newsletter

Your daily dose of news in health and medicine